Prot #APL2-304: A Phase III, Multi-Center, Randomized, Double-Masked, Sham-Controlled Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy with Sham Injections in Patients with Geographic Atrophy (GA) Secondary to Age-Related Macular Deg

Project: Research project

Project Details

StatusActive
Effective start/end date1/25/191/25/22

Funding

  • Covance Inc. (Prot #APL2-304)
  • Apellis Pharmaceuticals, Inc. (Prot #APL2-304)